microvigene software version 5.1.0.0 (VigeneTech inc)
90
Structured Review
VigeneTech inc
microvigene software version 5.1.0.0
Microvigene Software Version 5.1.0.0, supplied by VigeneTech inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/microvigene+version+5%2E1%2E0%2E0/microvigene+software/pmc11041871-135-16-20
Average 90 stars, based on 1 article reviews
Microvigene Software Version 5.1.0.0, supplied by VigeneTech inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/microvigene+version+5%2E1%2E0%2E0/microvigene+software/pmc11041871-135-16-20
Average 90 stars, based on 1 article reviews
microvigene software version 5.1.0.0 - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
Staining:Article Title: Defining the KRAS-regulated kinome in KRAS-mutant pancreatic cancer Article Snippet: TECAN laser scanner was used to scan Sypro Ruby and antibody-stained slides, and the images were analyzed using commercially available software (MicroVigene Version 5.1.0.0, Vigenetech) as previously described ( ). Article Title: Combination of ERK and autophagy inhibition as a treatment approach for pancreatic cancer Article Snippet: Images were analyzed using commercially available software (MicroVigene Version 5.1.0.0, Vigenetech) as described 54 . Article Title: Atypical KRASG12R Mutant Is Impaired in PI3K Signaling and Macropinocytosis in Pancreatic Cancer Article Snippet: Images were analyzed using commercially 675 available software (MicroVigene Version 5.1.0.0, Vigenetech) as previously described (50). Article Title: Enrichment of PI3K-AKT–mTOR Pathway Activation in Hepatic Metastases from Breast Cancer Article Snippet: Images were analyzed using the commercially available microarray software MicroVigene Version 5.1.0.0 (Vigenetech) or Genepix Pro 6.1 (Molecular Devices). Article Title: Low-Dose Vertical Inhibition of the RAF-MEK-ERK Cascade Causes Apoptotic Death of KRAS Mutant Cancers Article Snippet: TECAN laser scanner was used to scan Sypro Ruby and antibody stained slides, and the images were analyzed using commercially available software (MicroVigene Version 5.1.0.0, Vigenetech) as previously described ( ). Article Title: Atypical KRAS G12R Mutant Is Impaired in PI3K Signaling and Macropinocytosis in Pancreatic Cancer Article Snippet: Images were analyzed using commercially available software (MicroVigene Version 5.1.0.0, Vigenetech) as previously described ( 50 ). Software:Article Title: Defining the KRAS-regulated kinome in KRAS-mutant pancreatic cancer Article Snippet: TECAN laser scanner was used to scan Sypro Ruby and antibody-stained slides, and the images were analyzed using commercially available software (MicroVigene Version 5.1.0.0, Vigenetech) as previously described ( ). Article Title: Combination of ERK and autophagy inhibition as a treatment approach for pancreatic cancer Article Snippet: Images were analyzed using commercially available software (MicroVigene Version 5.1.0.0, Vigenetech) as described 54 . Article Title: Atypical KRASG12R Mutant Is Impaired in PI3K Signaling and Macropinocytosis in Pancreatic Cancer Article Snippet: Images were analyzed using commercially 675 available software (MicroVigene Version 5.1.0.0, Vigenetech) as previously described (50). Article Title: Enrichment of PI3K-AKT–mTOR Pathway Activation in Hepatic Metastases from Breast Cancer Article Snippet: Images were analyzed using the commercially available microarray software MicroVigene Version 5.1.0.0 (Vigenetech) or Genepix Pro 6.1 (Molecular Devices). Article Title: Low-Dose Vertical Inhibition of the RAF-MEK-ERK Cascade Causes Apoptotic Death of KRAS Mutant Cancers Article Snippet: TECAN laser scanner was used to scan Sypro Ruby and antibody stained slides, and the images were analyzed using commercially available software (MicroVigene Version 5.1.0.0, Vigenetech) as previously described ( ). Article Title: Atypical KRAS G12R Mutant Is Impaired in PI3K Signaling and Macropinocytosis in Pancreatic Cancer Article Snippet: Images were analyzed using commercially available software (MicroVigene Version 5.1.0.0, Vigenetech) as previously described ( 50 ). Microarray:Article Title: Defining the KRAS-regulated kinome in KRAS-mutant pancreatic cancer Article Snippet: TECAN laser scanner was used to scan Sypro Ruby and antibody-stained slides, and the images were analyzed using commercially available software (MicroVigene Version 5.1.0.0, Vigenetech) as previously described ( ). Article Title: Combination of ERK and autophagy inhibition as a treatment approach for pancreatic cancer Article Snippet: Images were analyzed using commercially available software (MicroVigene Version 5.1.0.0, Vigenetech) as described 54 . Article Title: Atypical KRASG12R Mutant Is Impaired in PI3K Signaling and Macropinocytosis in Pancreatic Cancer Article Snippet: Images were analyzed using commercially 675 available software (MicroVigene Version 5.1.0.0, Vigenetech) as previously described (50). Article Title: Enrichment of PI3K-AKT–mTOR Pathway Activation in Hepatic Metastases from Breast Cancer Article Snippet: Images were analyzed using the commercially available microarray software MicroVigene Version 5.1.0.0 (Vigenetech) or Genepix Pro 6.1 (Molecular Devices). Article Title: Low-Dose Vertical Inhibition of the RAF-MEK-ERK Cascade Causes Apoptotic Death of KRAS Mutant Cancers Article Snippet: TECAN laser scanner was used to scan Sypro Ruby and antibody stained slides, and the images were analyzed using commercially available software (MicroVigene Version 5.1.0.0, Vigenetech) as previously described ( ). Article Title: Atypical KRAS G12R Mutant Is Impaired in PI3K Signaling and Macropinocytosis in Pancreatic Cancer Article Snippet: Images were analyzed using commercially available software (MicroVigene Version 5.1.0.0, Vigenetech) as previously described ( 50 ). |